MARKET WIRE NEWS

Healthcare debate should focus on out-of-pocket costs, not list prices - Novartis CEO

Source: SeekingAlpha

2026-01-22 13:04:02 ET

More on Novartis

Read the full article on Seeking Alpha

For further details see:

Healthcare debate should focus on out-of-pocket costs, not list prices – Novartis CEO
Global X Genomics & Biotechnology ETF

NASDAQ: GNOM

GNOM Trading

0.96% G/L:

$45.80 Last:

2,767 Volume:

$45.51 Open:

mwn-app Ad 300

GNOM Latest News

December 09, 2025 04:15:00 pm
5 Small-cap Biotech ETFs to Watch
August 28, 2025 04:15:00 pm
How to Invest in Gene Stocks and ETFs
February 17, 2025 04:42:00 am
(GNOM) Investment Analysis and Advice

GNOM Stock Data

$50,934,390
1,094,657
N/A
N/A
US

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App